MedTrace Logo

Laser Therapy and Temporomandibular Disorders

NCT05620758 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-12-14

No results posted yet for this study

Summary

TMD involves a set of multiple clinical manifestations where the pain is prevalent. Treatment ideally should be noninvasive and innocuous such as photobiomodulation

Conditions

  • TMD

Interventions

OTHER

Nd YAG laser

patients from those diagnosed with TMD will receive Nd YAG laser 1064 nm

OTHER

diode laser (980 nm)

patients from those diagnosed with TMD will receive a diode laser (980 nm)

OTHER

diode laser (940 nm)

patients from those diagnosed with TMD will receive a diode laser (940 nm)

OTHER

diode laser (660 nm)

patients from those diagnosed with TMD will receive a diode laser (660 nm)

OTHER

diode laser (635 nm)

patients from those diagnosed with TMD will receive a diode laser (635 nm)

Sponsors & Collaborators

  • Hams Hamed Abdelrahman

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-01-30
Completion
2023-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05620758 on ClinicalTrials.gov